We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.775 | 0.75 | 0.80 | 0.775 | 0.775 | 0.78 | 221,809 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.52 | 2.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/11/2019 17:07 | If you had been short for a few weeks I think you would have mentioned it before | dave444 | |
11/11/2019 17:06 | That's funny, £I am underwater". I believe you are are drowning with "locked and loaded" posts. just -50% just today. In the morning it was closer to -65%. | mega bozzer | |
11/11/2019 17:05 | a row of sells, cumulative about 224K. Not one single for 2 hours. I am not desperate been short for a few weeks. Just today I am up 50% on this position. | mega bozzer | |
11/11/2019 17:04 | I guess if your short you can pray but those that sold out this morning are already underwater and if you were unwise enough to short today well you will have a sleepless night!! | dave444 | |
11/11/2019 17:03 | You should look at what the company say - how much do they estimate a partner in breast cancer will bring? | dave444 | |
11/11/2019 17:02 | IF this If that. That's merely dreaming. If only we were all billionaires. That's not how this works. Surely it's the first of collapse and see the row of sells at -12% discount to bid, one can envisage sub 5p looms | mega bozzer | |
11/11/2019 17:01 | It would appear your the desperate one!!I am happy to hold! | dave444 | |
11/11/2019 17:00 | Interesting posts. Locked and loaded. Maybe that's why you are desperate. on 6th of Nov £1-£1.50 but on 12 Oct it was only 50p dave444 - 06 Nov 2019 - 20:39:59 - 1332 of 1372 £1/share is the minimum this will be at post deal! Probably more realistically £1.50/share! dave444 - 04 Nov 2019 - 10:49:48 - 1331 of 1372 Excellent post! I am locked and loaded I assume results will be known in December dave444 - 12 Oct 2019 - 20:43:32 - 1280 of 1372 Such a load of players here including penny falls and even nobby has demonstrated his in and out nature Interesting that on a successful outcome a large upfront payment awaits! Let me think! 50p a share! | mega bozzer | |
11/11/2019 16:58 | If they get the partner premium they anticipate it will prove otherwise | dave444 | |
11/11/2019 16:57 | They also hope to conclude partner coalition in the near future - you should check out what they say that will mean | dave444 | |
11/11/2019 16:57 | I think people selling at 16.50p are bright, don't you think so. It's -55% from that point dave444 - 06 Nov 2019 - 20:39:59 - 1332 of 1372 £1/share is the minimum this will be at post deal! Probably more realistically £1.50/share! So selling out at 16.50p is not very bright!!!!! | mega bozzer | |
11/11/2019 16:56 | Company is funded for all activity including trial work until mid 2021!It is on their website | dave444 | |
11/11/2019 16:54 | Row of sells. why? They are not exactly going to say we want funding right. 5p was low today. Should be tested again with the amount of sells late afternoon. I am not trying anything merely expressing my views. There's no need to red mark me though. | mega bozzer | |
11/11/2019 16:51 | Not according to the company!Maybe you should try harder! | dave444 | |
11/11/2019 16:49 | Looks like someone got impaled here. Placing has to happen. Check out OPEX. one day -50%? maybe another -50% tomorrow. | mega bozzer | |
11/11/2019 16:11 | Thought it worth posting this from the April investor presentation - could easily secure partnership for breast cancer and it quotes funding secured until mid 2021! Phase II success, and another Phase II result in 2019, sets scene for partnering and transformation The recent success of the STEM trial lays the ground for STEM II – a randomised, double-blind, placebo controlled trial in patients with metastatic breast cancer Full STEM results to be submitted for presentation at ESMO 2019 at the end of September Near-term funding requirement to: Provide working capital through to mid-2021 and strengthen the balance sheet for partnering Develop product formulation (solid tablet) for use in STEM II and other investigator-led clinical studies Rich vein of news flow through 2019 including: Results from SAS Phase II trial Further STEM results presented at ESMO 2019 First potential partnership deal Announcement of first investigator-initiat | dave444 | |
11/11/2019 15:37 | Interesting at 8p EVG market value is only £10m yet last update mentioned £7.5m in cash | dave444 | |
11/11/2019 14:25 | The more I read the first RNS, the more of a shocker it clearly is! The second RNS was probably issued to prevent even greater carnage in later trading. I think this might return to 9p or 10p in the short to medium term, and will certainly attract the traders for a bit too now. Good luck in future investments PF and other fellow unfortunates; hopefully better results will await us elsewhere. | lovewinshatelosses | |
11/11/2019 13:22 | I could not sell in the morning. Did it in the dead cat glad, I wanted. This will sink in the close. Needs loads of money for trials. | shakesmaster | |
11/11/2019 12:54 | LWHL...Hi.. I’m out! ...they’ll need a fundraiser for next stage of breast cancer trials and all other studies in formative stages. I’ll take the loss and move on.. Goodbye all...total shocker that - expected some primary endpoint mitigation, but nada. Shocker. | pennyfalls | |
11/11/2019 12:23 | Also learn to spell Pharma | dave444 | |
11/11/2019 12:23 | It was much more than 1 person!Keep trying work a bit harder! | dave444 | |
11/11/2019 12:20 | One person is not considered successful. What's cash burn per month? The market thinks ahead. 2p may be worth a punt. | utorrent | |
11/11/2019 12:15 | A does of realism!At 3p the market capitalization is £4m!They have much more than that in cash plus a successful breast cancer result! | dave444 | |
11/11/2019 11:25 | Farma companies do fall for weeks months. The way MMS did not let people buy but instead bid getting to 5.00p, I think there's a big seller. Most likely 5.0p close and more damages tomorrow. Maybe a punt at 2p for the dead cat bounce to 3.0p | utorrent |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions